Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/21/1996US5519017 Pharmaceutic formulation for the treatment of alcoholism
05/21/1996US5519016 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent
05/21/1996US5519015 Bactericides
05/21/1996US5519014 Salilcylic acid derivatives
05/21/1996US5519012 Inclusion complexes of optically active 1,4-dihydropyridines with methyl-β-cyclodextrin
05/21/1996US5519011 Food composite performing function of improving serum lipid
05/21/1996US5519009 Interleukins
05/21/1996US5519008 Antiinflammatory agents
05/21/1996US5519007 Lysosphingolipid derivatives
05/21/1996US5519006 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity
05/21/1996US5519005 Guanidine terminated peptides for treatment of thrombosis, antitumor agents, autoimmune diseases and immunology
05/21/1996US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability
05/21/1996US5518918 Microfloral biomass having omega-3 highly unsaturated fatty acids
05/21/1996US5518914 Growth medium containing a complex of prealbumin, a retinoid and retinol-binding protein used to enhance B cell growth
05/21/1996US5518911 Human PAK65
05/21/1996US5518902 High pullulan content product, and its preparation and uses
05/21/1996US5518879 Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination
05/21/1996US5518738 Nanoparticulate nsaid compositions
05/21/1996US5518735 Anticoagulants administered by mouth
05/21/1996US5518734 Transdermal delivery system for estradiol and process for manufacturing said device
05/21/1996US5518733 Cosmetic compositions containing oligosaccharides
05/21/1996US5518731 Nonaqueous fluorinated drug delivery vehicle suspensions
05/21/1996US5518729 N-substituted pyridones
05/21/1996US5518725 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
05/21/1996US5518187 Method of grinding pharmaceutical substances
05/21/1996CA2127111C A method for preparing enteric-coated oral drugs containing acid-unstable compounds
05/21/1996CA2090738C Use of paf
05/21/1996CA2043860C Pyrrolo-pyridine derivatives, a process for their preparation and therapeutic compositions containing them
05/21/1996CA2017573C 4-(hydroxydiphenylmethyl)-1-piperidylphenylalkane derivatives as antihistamines and a method of treatment of an allergic response
05/21/1996CA1338337C Method and composition for the treatment of burns
05/19/1996CA2163158A1 Methods for inhibiting bone loss
05/19/1996CA2163156A1 Methods for lowering serum cholesterol
05/18/1996CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
05/17/1996WO1996014435A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS
05/17/1996WO1996014433A1 Process for determining the activity of specific phosphotyrosine phosphatases and specific effectors thereof in intact cells
05/17/1996WO1996014425A1 Polysaccharides having a high iduronic acid content
05/17/1996WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014330A1 Amino acid nucleic acids
05/17/1996WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014327A1 Antifungal sordaridin derivatives
05/17/1996WO1996014326A1 Antifungal sordaridin derivatives
05/17/1996WO1996014325A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996WO1996014324A1 Smooth muscle cell proliferation inhibitors
05/17/1996WO1996014323A1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996WO1996014320A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors
05/17/1996WO1996014318A1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
05/17/1996WO1996014317A1 Novel piperidine derivatives with paf antagonist activity
05/17/1996WO1996014316A1 A method of treating urinary bladder dysfunctions
05/17/1996WO1996014314A2 Thiepane compounds inhibiting and detecting hiv protease
05/17/1996WO1996014309A1 Taxane derivatives
05/17/1996WO1996014308A1 Taxane derivatives
05/17/1996WO1996014307A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
05/17/1996WO1996014306A1 Forms a and b of n-[[[2-[[[2-[(diaminomethylen)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylen]-4-bromobenzenosulphonamide
05/17/1996WO1996014302A1 Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
05/17/1996WO1996014300A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities
05/17/1996WO1996014090A1 Compositions comprising carbazoles and cyclodextrins
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014075A1 Synthetic insulin mimetic substances
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy
05/17/1996WO1996014072A1 Methods and compositions for stimulating tissue growth and epithelial moisturization
05/17/1996WO1996014071A1 Combination of chemical compounds used as a medicament intended to suppress the dependence of individuals to opioids
05/17/1996WO1996014070A1 Cisapride extended release oral compositions
05/17/1996WO1996014069A1 Percutaneously absorbable patch
05/17/1996WO1996014068A1 Medicament for the treatment of diseases of the gastrointestinal tract
05/17/1996WO1996014067A1 Cysteine protease and serine protease inhibitors
05/17/1996WO1996014066A1 A method of treating urinary bladder dysfunctions
05/17/1996WO1996014065A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/17/1996WO1996014064A1 Method and composition for antiviral therapy
05/17/1996WO1996014063A1 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
05/17/1996WO1996014062A1 A delivery system for antimethanogenic agents
05/17/1996WO1996014060A1 Use of receptor agonists to stimulate superoxide dismutase activity
05/17/1996WO1996014059A1 Pharmaceutical composition containing a fusible carrier and method for producing the same
05/17/1996WO1996014058A1 Melt-extruded orally administrable opioid formulations
05/17/1996WO1996014048A1 Treatment of keratinic and psoriatic disorders with a nail lacquer containing a vitamin d metabolite or derivative and/or a vitamin a derivative
05/17/1996WO1996008270A3 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
05/17/1996WO1996007392A3 Oligonucleotide prodrugs
05/17/1996WO1996004266A3 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
05/17/1996WO1995033463A3 Synergistic antibiotic compositions containing a perphyrin and an antibiotic
05/17/1996CA2507753A1 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
05/17/1996CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996CA2204531A1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996CA2204530A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996CA2204529A1 Smooth muscle cell proliferation inhibitors
05/17/1996CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204415A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities
05/17/1996CA2204366A1 Polysaccharides having a high iduronic acid content
05/17/1996CA2204361A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/17/1996CA2204358A1 A delivery system for antimethanogenic agents
05/17/1996CA2203664A1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity
05/17/1996CA2203661A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors
05/17/1996CA2203651A1 Dna ligase iv
05/17/1996CA2203570A1 Thiepane compounds inhibiting and detecting hiv protease
05/17/1996CA2202274A1 Amino acid nucleic acids
05/17/1996CA2197306A1 Cysteine protease and serine protease inhibitors
05/17/1996CA2180162A1 Synthetic insulin mimetic substances
05/17/1996CA2180117A1 Combination of chemical compounds used as a medicament intended to suppress the dependence of individuals to opioids
1 ... 6916 6917 6918 6919 6920 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 ... 7860